A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

This study will evaluate the relationship between time since onset of macular oedema symptoms and the achievement of vision gain in patients prescribed OZURDEX®. All care and diagnostic procedures provided are at the discretion of the participating physicians according to their clinical judgment and local standard of medical care.

Inclusion Criteria:

• Diagnosis of macular edema following retinal vein occlusion
• Prescribed OZURDEX®

Exclusion Criteria:

• Previous treatment with OZURDEX®